Table of Contents
Overview
LTB (Lymphotoxin Beta) is a member of the tumor necrosis factor (TNF) superfamily, which plays a role in the development and organization of secondary lymphoid tissues and in the regulation of immune responses. LTB is one of a number of genes affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. Although the mutation incidence is relatively high in DLBCL, little is known about the role of these mutations in lymphomagenesis. The mutation pattern overall implies a selective pressure to acquire loss-of-function mutations in LTB.
Relevance tier by entity
| Entity | Tier | Description |
|---|---|---|
| 1 | High-confidence DLBCL gene | |
| 2 | Role of LTB mutations in FL requires confirmation | |
| 1 | High-confidence PMBL gene |
Mutation incidence in large patient cohorts (GAMBL reanalysis)
DLBCL
| Entity | Collection | N | mutated | Incidence | 95% CI |
|---|---|---|---|---|---|
| DLBCL | GAMBL without Reddy | 1,089 | 106 | 0.0973 | [0.0797,0.1149] |
| DLBCL | GAMBL with Reddy | 2,088 | 106 | 0.0508 | [0.0414,0.0602] |
| DLBCL | BC | 231 | 26 | 0.1126 | [0.0718,0.1533] |
| DLBCL | Dana-Farber | 303 | 28 | 0.0924 | [0.0598,0.125] |
| DLBCL | NCI | 470 | 40 | 0.0851 | [0.0599,0.1103] |
| DLBCL | Reddy | 999 | 0 | 0.0001 | [0,7e-04] |
| DLBCL | DLBCL_ICGC | 85 | 12 | 0.1412 | [0.0672,0.2152] |
FL
| pathology | Collection | N | mutated | Incidence | CI |
|---|---|---|---|---|---|
| FL | GAMBL without Crouch | 642 | 48 | 0.0748 | [0.0544,0.0951] |
| FL | GAMBL with Crouch | 1,189 | 94 | 0.0791 | [0.0637,0.0944] |
| FL | BC | 379 | 33 | 0.0871 | [0.0587,0.1155] |
| FL | Kalmbach | 164 | 11 | 0.0671 | [0.0288,0.1054] |
| FL | Crouch | 547 | 46 | 0.0841 | [0.0608,0.1074] |
| FL | FL_ICGC | 99 | 4 | 0.0404 | [0.0016,0.0792] |
BL
| pathology | Collection | N | mutated | Incidence | CI |
|---|---|---|---|---|---|
| BL | GAMBL without Panea | 309 | 7 | 0.0036 | [0,0.0102] |
| BL | GAMBL without ICGC/Zhou | 320 | 13 | 0.0375 | [0.0168,0.0583] |
| BL | GAMBL with Panea | 410 | 13 | 0.0047 | [0,0.0112] |
| BL | BLGSP | 219 | 7 | 0.0320 | [0.0087,0.0553] |
| BL | Zhou/ICGC | 90 | 0 | 0.0011 | [0,0.008] |
| BL | Panea | 101 | 6 | 0.0594 | [0.0133,0.1055] |
Mutation pattern and selective pressure estimates
| Entity | Missense dN/dS | Nonsense dN/dS | Q value |
|---|---|---|---|
| BL | 3.6041 | 0.0000 | 1 |
| FL | 2.8220 | 18.5768 | 0 |
| DLBCL | 1.0495 | 5.3066 | 0 |
aSHM regions
| chr_name | hg19_start | hg19_end | region | regulatory_comment |
|---|---|---|---|---|
| chr6 | 31548325 | 31550717 | intron-1 | enhancer |
Cannot include /browser_LTB.md - does not exist yet
Expression
History
%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
timeline
title Publication timing
2018-05-01 : Chapuy : DLBCL
2019-08-20 : Desch : PMBL
References
1.
Desch AK, Hartung K, Botzen A, Brobeil A,
Rummel M, Kurch L, Georgi T, Jox T, Bielack S, Burdach S, Classen CF,
Claviez A, Debatin KM, Ebinger M, Eggert A, Faber J, Flotho C, Frühwald
M, Graf N, Jorch N, Kontny U, Kramm C, Kulozik A, Kühr J, Sykora KW,
Metzler M, Müller HL, Nathrath M, Nüßlein T, Paulussen M, Pekrun A,
Reinhardt D, Reinhard H, Rössig C, Sauerbrey A, Schlegel PG, Schneider
DT, Scheurlen W, Schweigerer L, Simon T, Suttorp M, Vorwerk P, Schmitz
R, Kluge R, Mauz-Körholz C, Körholz D, Gattenlöhner S, Bräuninger A. Genotyping circulating
tumor DNA of pediatric Hodgkin lymphoma.
Leukemia. 2020 Jan;34(1):151–166.
2.
Chapuy B, Stewart C, Dunford AJ, Kim J,
Kamburov A, Redd RA, Lawrence MS, Roemer MGM, Li AJ, Ziepert M, Staiger
AM, Wala JA, Ducar MD, Leshchiner I, Rheinbay E, Taylor-Weiner A,
Coughlin CA, Hess JM, Pedamallu CS, Livitz D, Rosebrock D, Rosenberg M,
Tracy AA, Horn H, van Hummelen P, Feldman AL, Link BK, Novak AJ, Cerhan
JR, Habermann TM, Siebert R, Rosenwald A, Thorner AR, Meyerson ML, Golub
TR, Beroukhim R, Wulf GG, Ott G, Rodig SJ, Monti S, Neuberg DS, Loeffler
M, Pfreundschuh M, Trümper L, Getz G, Shipp MA. Molecular subtypes of
diffuse large B cell lymphoma are associated with distinct
pathogenic mechanisms and outcomes. Nat Med. 2018 May;24(5):679–690.
PMCID: PMC6613387
3.
Panea R, Love C, Shingleton JR, Reddy A, Bailey
J, Moormann A, Otieno J, Ong’echa J, Oduor C, Schroêder K, Masalu N,
Chao N, Agajanian M, Major M, Fedoriw Y, Richards K, Rymkiewicz G, Miles
R, Alobeid B, Bhagat G, Flowers C, Ondrejka S, Hsi E, Choi W, Au-Yeung
R, Hartmann W, Lenz G, Meyerson H, Lin YY, Zhuang Y, Luftig M, Waldrop
A, Dave T, Thakkar D, Sahay H, Li G, Palus B, Seshadri V, Kim S,
Gascoyne R, Levy S, Mukhopadhyay M, Dunson D, Dave S. The whole genome
landscape of Burkitt lymphoma subtypes. Blood. 2019;


